 |
Drug developers have shown that the novel antiviral neuraminidase inhibitor R-125489 administered as its prodrug CS-8958 works effectively against the highly pathogenic influenza A virus H5N1, including oseltamivir-resistant strains. More...
[11 Mar 2010]
|
|
|
|
|
